Medical Research News

RSS

Researchers reveal mechanisms of how CDK12 alterations drive prostate cancer development

When researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate cancer, they knew they needed to understand how this genetic alteration was driving cancer and how to target it with treatment.

4 Oct 2024

Jefferson Lab team explores proton therapy as a safer cancer treatment

Radiation therapy techniques have been used for more than a century to treat cancers. Physicists in the Radiation Detector and Imaging group and associated with the Biomedical Research & Innovation Center (BRIC) at the U.S. Department of Energy's Thomas Jefferson National Accelerator Facility have been for several years pursuing radiation therapy technology improvements in collaboration with the Hampton University Proton Cancer Institute (HUPCI).

4 Oct 2024

Women who inject drugs are vulnerable to endocarditis, study shows

People who inject drugs are dying at an alarming rate from endocarditis, a serious but treatable heart-valve infection.

4 Oct 2024

Exploring the venomous potential of marine crustaceans for drug development

Many animals use venoms for self-defense or hunting. The components of such venom, known as toxins, interfere with various physiological processes - which is also the reason why they are so interesting for the development of new pharmacological agents.

4 Oct 2024

Engineered E. coli shows promise in cancer immunotherapy

Recent research has shown that certain forms of E. coli bacteria tend to colonize hypoxic areas of the body, including tumors, suggesting they might be playing a role in cancer therapeutics.

4 Oct 2024

Collaborative study investigates underlying cause of neuropsychiatric symptoms in Parkinson's disease

Parkinson's disease is most known for its movement-related symptoms: tremors and rigidity, slowness and falls, caused by the loss of the brain's dopamine-producing neurons.

4 Oct 2024

New analysis raises concerns over Medicare Advantage spending for veterans

From 2011 to 2020, the Veterans Health Administration spent $78 billion to care for U.S. military veterans enrolled in Medicare Advantage plans, raising questions about federal overpayments to those private plans.

4 Oct 2024

Study identifies a new target for developing atrial fibrillation therapy

A new study by researchers at the University of Arizona College of Medicine – Phoenix and the University of California Davis Health identified a new target for developing a therapy to treat atrial fibrillation, the most common type of abnormal heart rhythm.

4 Oct 2024

Innovative study captures real-time data on balance loss in older adults

Researchers at Virginia Tech are using wrist-worn voice recorders to capture real-world data to better understand what happens when people lose their balance.

4 Oct 2024

New strategy uses bacteriophages to combat drug-resistant infections

Researchers have a new battle tactic to fight drug-resistant bacterial infections. Their strategy involves using collections of bacteriophages, viruses that naturally attack bacteria.

4 Oct 2024

Study identifies ophthalmic acid as an alternative to dopamine in motor control

A research team from the University of California, Irvine is the first to reveal that a molecule in the brain – ophthalmic acid – unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic target for Parkinson's and other movement diseases.

4 Oct 2024

New approach enhances radiation treatment for lung cancer brain metastases

In new research, a team led by University of Cincinnati researchers has identified a potential new way to make radiation more effective and improve outcomes for patients with lung cancer that has spread to the brain.

4 Oct 2024

A decade of CCBHCs enhances access to mental health care across the U.S.

A decade after the establishment of the certified community behavioral health clinic (CCBHC) model, more than 60 percent of the US population has access to such facilities and the mental health and substance use disorder treatment services they provide, according to a new study led by researchers at the NYU School of Global Public Health.

4 Oct 2024

New insights into the role of gamma-delta T cells across 33 cancer types revealed

A new study published in Cell Press reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

4 Oct 2024

Study unravels the unique patterns of brain shrinkage in Alzheimer's disease

The way in which brains shrink in those who develop Alzheimer's disease follows no specific or uniform pattern, finds a new study by researchers at UCL and Radboud University in the Netherlands.

4 Oct 2024

Identical twins study uncovers insights into multiple sclerosis mechanisms

Multiple sclerosis (MS) is a chronic inflammatory disease in which the immune system attacks the central nervous system.

4 Oct 2024

LXRβ emerges as a promising target for depression and anxiety treatments

In a state-of-the-art Bench to Bedside review published in the journal Brain Medicine (Genomic Press), researchers Dr. Xiaoyu Song and Professor Jan-Åke Gustafsson from the University of Houston and Karolinska Institutet (Sweden) shed light on the therapeutic potential of liver X receptor beta (LXRβ) in treating depression and anxiety.

4 Oct 2024

Imagery rescripting offers new hope for treating hoarding disorder

Rehearsing alternative outcomes of discarding through imagery rescripting shows promise as a treatment strategy for people who hoard, a study by UNSW psychology researchers has shown.

4 Oct 2024

Greater bean and pulse intake linked to improved nutrient intake and diet quality in American adults

New research showing the association between greater bean and pulse consumption and improved shortfall nutrient intakes and a higher diet quality in American adults will be presented during the Academy of Nutrition and Dietetics (the Academy) Food & Nutrition Conference & Expo (FNCE) 2024 in Minneapolis, MN.

4 Oct 2024